Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
Clinical trial NCT00493454 · TERMINATED
Trial details
- NCT number
- NCT00493454
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2011-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.